Evidence map›Paper›PMID 25505243›Full record

ArticleThe Journal of biological chemistry2015

Heart mitochondrial TTP synthesis and the compartmentalization of TMP.

Vasudeva G Kamath, Chia-Heng Hsiung, Zachary J Lizenby, Edward E McKee

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Uridine Treatment of the First Known Case of SLC25A36 Deficiency.International journal of molecular sciences · 2021
    Article
  6. Review
  7. Article
  8. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vasudeva G KamathFrom the Department of Foundational Sciences, College of Medicine, Central Michigan University, Mount Pleasant, Michigan 48859.
Chia-Heng HsiungFrom the Department of Foundational Sciences, College of Medicine, Central Michigan University, Mount Pleasant, Michigan 48859.
Zachary J LizenbyFrom the Department of Foundational Sciences, College of Medicine, Central Michigan University, Mount Pleasant, Michigan 48859.
Edward E McKeeFrom the Department of Foundational Sciences, College of Medicine, Central Michigan University, Mount Pleasant, Michigan 48859 mckee1ee@cmich.edu.
Central Michigan University · US

Funding

Metabolism and toxicity of nucleoside reverse transcriptase inhibitors in non-repR01HL096480 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI MCKEE, EDWARD E. · 2010 to 2013
$1.4M
NHLBI NIH HHS R01 HL096480NHLBI NIH HHS R01/HL096480
6 · The paper itself

Abstract

The primary pathway of TTP synthesis in the heart requires thymidine salvage by mitochondrial thymidine kinase 2 (TK2). However, the compartmentalization of this pathway and the transport of thymidine nucleotides are not well understood. We investigated the metabolism of [(3)H]thymidine or [(3)H]TMP as precursors of [(3)H]TTP in isolated intact or broken mitochondria from the rat heart. The results demonstrated that [(3)H]thymidine was readily metabolized by the mitochondrial salvage enzymes to TTP in intact mitochondria. The equivalent addition of [(3)H]TMP produced far less [(3)H]TTP than the amount observed with [(3)H]thymidine as the precursor. Using zidovudine to inhibit TK2, the synthesis of [(3)H]TTP from [(3)H]TMP was effectively blocked, demonstrating that synthesis of [(3)H]TTP from [(3)H]TMP arose solely from the dephosphorysynthase pathway that includes deoxyuridine triphosphatelation of [(3)H]TMP to [(3)H]thymidine. To determine the role of the membrane in TMP metabolism, mitochondrial membranes were disrupted by freezing and thawing. In broken mitochondria, [(3)H]thymidine was readily converted to [(3)H]TMP, but further phosphorylation was prevented even though the energy charge was well maintained by addition of oligomycin A, phosphocreatine, and creatine phosphokinase. The failure to synthesize TTP in broken mitochondria was not related to a loss of membrane potential or inhibition of the electron transport chain, as confirmed by addition of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone and potassium cyanide, respectively, in intact mitochondria. In summary, these data, taken together, suggest that the thymidine salvage pathway is compartmentalized so that TMP kinase prefers TMP synthesized by TK2 over medium TMP and that this is disrupted in broken mitochondria.

Indexed as

AnimalsCarbonyl Cyanide m-Chlorophenyl HydrazoneCreatine KinaseCytosolElectron TransportFemaleMembrane Potential, MitochondrialMitochondria, HeartMyocardiumOligomycinsPhosphocreatinePhosphorylationPotassium CyanideRatsRats, Sprague-DawleyThymidinecarbonylcyanide 4-trifluoromethoxyphenylhydrazoneCarbonyl Cyanide m-Chlorophenyl HydrazoneCreatine Kinaseoligomycin AOligomycinsPhosphocreatinePotassium CyanideThymidinethymidine 5'-triphosphateThymidine Kinasethymidine kinase 2Thymidine MonophosphateThymine NucleotidesZidovudineMitochondriaMitochondrial MetabolismNucleoside/Nucleotide BiosynthesisNucleoside/Nucleotide MetabolismThymidine Kinase 2

Identifiers

PMID25505243
PMCPMC4303658
OpenAlexW2008680918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.